AdAlta (1AD) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period AdAlta to Showcase ‘East to West’ Strategy at Biopharma SummitMarch 3, 2025 | tipranks.comAdAlta Limited Reports Significant Revenue Decline in H1 2024February 20, 2025 | tipranks.comLong Shortz with AdAlta: The East to West vision for immunotherapyFebruary 10, 2025 | msn.comAdAlta Issues New Shares to Employees Under Equity PlanFebruary 6, 2025 | tipranks.comAdAlta prioritises ‘East to West’ cellular immunotherapy strategy to drive value creationFebruary 6, 2025 | msn.com'East to West': AdAlta unveils new strategy to find drug candidates, but appears to've ditched AD-214February 5, 2025 | msn.comAdAlta Limited Unveils Strategic ‘East to West’ Cellular Immunotherapy ApproachFebruary 5, 2025 | tipranks.comRoad to 2025: AdAlta’s push to advance lead drug AD-214 for deadly IPFJanuary 7, 2025 | msn.comInsider Traders Lose AU$43k As AdAlta DropsDecember 20, 2024 | uk.finance.yahoo.comWTF with 1AD: New approach to treating fibrosis with lead i-body drug candidateNovember 24, 2024 | msn.comAdAlta Limited Advances Drug Discovery and PartnershipsNovember 21, 2024 | markets.businessinsider.comAdAlta Ltd. Showcases Drug Development ProspectsNovember 21, 2024 | markets.businessinsider.comAdAlta Strengthens Board with New AppointmentsNovember 17, 2024 | markets.businessinsider.comAdAlta to Showcase Innovative Drug Discovery at TSN ConferenceOctober 30, 2024 | markets.businessinsider.comLong Shortz with AdAlta: Growing in confidence every day for fibrotic medical treatmentsOctober 28, 2024 | msn.comAdAlta Limited Strengthens Clinical and Strategic InitiativesOctober 24, 2024 | markets.businessinsider.comAdAlta secures top talent to lead AdCella and AdSolis as boost in clinical activity loomsOctober 23, 2024 | msn.comClosing Bell: WiseTech drags again; 29Metals sinks 20pc on copper outputOctober 23, 2024 | msn.comAdAlta Strengthens Leadership for Cancer and Fibrosis TherapiesOctober 23, 2024 | markets.businessinsider.comLong Shortz with AdAlta: Global health experts recruited for idiopathic pulmonary fibrosis drugOctober 10, 2024 | msn.comAdAlta forms clinical advisory board to advance IPF drug candidateOctober 9, 2024 | msn.comUp 19% in 2024, is it time to buy or sell Coles shares?September 18, 2024 | fool.com.auClosing Bell: ASX up 0.22pc after slow start; iron ore miners, REA weigh on marketSeptember 2, 2024 | msn.comHealth Kick Podcast: Creating hope for debilitating diseasesAugust 27, 2024 | msn.comLong Shortz with AdAlta: New quarter, twice the cashAugust 1, 2024 | msn.comAdAlta Ltd 1ADMay 17, 2024 | morningstar.comLong Shortz with AdAlta: Progressive partnership to spread life-saving immunotherapiesMay 14, 2024 | msn.comMarket Highlights: Novovax doubles; Chalmers calls critical minerals a ‘golden opportunity’May 13, 2024 | msn.comAdAlta secures Cell Therapies as cellular immunotherapies manufacturerMay 13, 2024 | msn.comAdAlta locks in $3.7m to speed up Phase II clinical trials, near-term partnershipsApril 29, 2024 | msn.comLong Shortz with AdAlta: Strengthening bonds in the fight against cancerApril 8, 2024 | msn.comAdAlta and SYNthesis BioVentures collaborate on advanced cell-based cancer immunotherapyApril 7, 2024 | msn.comAdAlta delivers positive Phase I Extension Study results for AD-214March 8, 2024 | finance.yahoo.comScoPo’s (actually Wilkie’s) Powerplays: Health stocks rise as AdAlta soars 17% on trial resultsMarch 8, 2024 | msn.comLeeds - Weather warnings issuedFebruary 15, 2024 | bbc.comCountdown on to AdAlta trial results as biotech advances partner discussionsFebruary 11, 2024 | msn.comAdAlta Insiders Placed Bullish Bets Worth AU$850.2kFebruary 4, 2024 | finance.yahoo.comAdAlta advancing partnering programs as AD-214 participants receive final doseJanuary 22, 2024 | msn.comAdalta Ltd (1AD)January 9, 2024 | es.investing.comWhat’s in store for 2024: AdAltaJanuary 4, 2024 | msn.comMoney Talks: Keep an eye on these tasty precious metal and biotech plays in 2024December 28, 2023 | msn.comLong Shortz with AdAlta: How the company has potentially broken the malaria life cycleDecember 19, 2023 | msn.com‘World first’: AdAlta’s i-body platform a breakthrough for malaria treatmentDecember 18, 2023 | msn.comAdAlta on track for trial readout in Q1 2024 after $1.65m cap raiseDecember 13, 2023 | msn.com‘Best place we’ve ever been’: AdAlta looks to monetise lead asset in 2024November 30, 2023 | msn.comASX Health Stocks: Painchek’s Europe patent accepted; and HeraMed signs deal with Telstra HealthNovember 20, 2023 | msn.comAdAlta’s latest results bolster safety profile and dose selection for primary asset, enhancing partnering, reducing Phase 2 trial risksNovember 20, 2023 | msn.comAdAlta raises $1.65 million in oversubscribed placement to support clinical study and partner discussionsNovember 18, 2023 | proactiveinvestors.com.auIt's Probably Less Likely That AdAlta Limited's (ASX:1AD) CEO Will See A Huge Pay Rise This YearNovember 15, 2023 | finance.yahoo.comAdAlta closes oversubscribed $1.65 million raiseNovember 7, 2023 | proactiveinvestors.com.au Remove Ads Get AdAlta News Delivered to You Automatically Sign up to receive the latest news and ratings for 1AD and its competitors with MarketBeat's FREE daily newsletter. Email Address 1AD Media Mentions By Week 1AD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. 1AD News Sentiment▼0.000.69▲Average Medical News Sentiment 1AD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. 1AD Articles This Week▼00▲1AD Articles Average Week Remove Ads Get AdAlta News Delivered to You Automatically Sign up to receive the latest news and ratings for 1AD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AGNPF News Today AKBLF News Today DRTSW News Today ARNI News Today ASPHF News Today ASCLF News Today AVCTF News Today AWKNF News Today BRRGF News Today BCTXW News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:1AD) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersMarch 18th: Gold SHOCK? On March 18th, an event is taking place that could completely shock the market. Stocks could go ballistic…...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the...Timothy Sykes | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredThis Crypto Is Set to Explode in FebruaryThe world's central banks are making bold moves—and it's raising eyebrows. What do they know that you don...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdAlta Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share AdAlta With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
